Sharing Insight on Myeloma, CAR T, and More in San Francisco

By
Article

We visited San Francisco, California for a State of the Science Summit on Hematologic Malignancies. The meeting covered novel agents and combinations in lymphoma, updates in acute and chronic leukemias, and modalities in the management of multiple myeloma.

We visited San Francisco, California for a State of the Science SummitTM on Hematologic Malignancies. The meeting covered novel agents and combinations in lymphoma, updates in acute and chronic leukemias, and modalities in the management of multiple myeloma.

Recent Videos
Linda Marbán, PhD, the CEO of Capricor Therapeutics
Cassandra Gorsuch, PhD, chief scientific officer at Precision
Cassandra Gorsuch, PhD, chief scientific officer at Precision
Linda Marbán, PhD, the CEO of Capricor Therapeutics
Matthew Wicklund, MD, a professor of neurology at the University of Texas Health Science Center San Antonio
Matthew Wicklund, MD, a professor of neurology at the University of Texas Health Science Center San Antonio
Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center
Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center
Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center
Renier Brentjens, MD, PhD, the chair of the department of medicine and the deputy director at Roswell Park Comprehensive Cancer Center
Related Content
CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – May 2, 2025

Noah Stansfield
May 2nd 2025
Article

Review top news and interview highlights from the week ending May 2, 2025.

ImmunoLogic

ImmunoLogic, Episode 3: "Breaking the Brain’s Barrier: CAR T-Cells Take on Glioblastoma" With Marcela Maus, MD, PhD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Marcela V. Maus, MD, PhD;Noah Stansfield;Matt Hoffman
April 8th 2025
Podcast

In Episode 3 of ImmunoLogic, Marcela Maus, MD, PhD, discussed her research on CAR-T for treating glioblastoma.

FDA Activity Recap: April 2025 Features Major Approval in RDEB, Multiple Breakthrough Therapy Designations, and More

FDA Activity Recap: April 2025 Features Major Approval in RDEB, Multiple Breakthrough Therapy Designations, and More

Noah Stansfield
May 1st 2025
Article

Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.

ImmunoLogic

ImmunoLogic, Episode 2: "Charting New Frontiers in CAR T-Cell Safety" With Bruce Levine, PhD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Noah Stansfield;Matt Hoffman
March 11th 2025
Podcast

In Episode 2 of ImmunoLogic, Bruce Levine, PhD, discussed the current the risk-benefit-ratio for CAR-T therapy.

The Evolving Landscape of Gene and Cell Therapies in Parkinson Disease: Pipeline Highlights

The Evolving Landscape of Gene and Cell Therapies in Parkinson Disease: Pipeline Highlights

Isabella Ciccone, MPH;Marco Meglio;Noah Stansfield;Matt Hoffman
April 30th 2025
Article

Emerging gene and cell therapies aim to slow Parkinson disease progression. Explore clinical updates on seven promising candidates in development.

Matthew Alexander, PhD

Exploring New Pathways in Muscular Dystrophy Research: From Fibrosis to Function

Marco Meglio
April 30th 2025
Article

Matthew Alexander, PhD, a neuromuscular expert, discussed the evolving landscape of targeted therapies in muscular dystrophies, from fibrosis and glycosylation to combination strategies with gene therapy.

© 2025 MJH Life Sciences

All rights reserved.